Infant formula safety remains under close federal scrutiny in the United States after a series of contamination investigations and supply disruptions over the past several years. That focus sharpened again on June 13, when Nara Organics recalled all lots of its Whole Milk Organic Powdered Infant Formula after three infant botulism cases were identified across California, Pennsylvania, and Washington.
Nara Organics recalled all lots after three infant illnesses
Nara Organics said it voluntarily recalled all cans of its Whole Milk Organic Powdered Infant Formula currently on the U.S. market after the FDA and CDC notified the company on June 12, 2026, about three infant botulism cases in babies who had consumed the formula. The FDA said Nara agreed to the recall on June 13, 2026, and the agency’s outbreak page lists three illnesses, three hospitalizations, and no deaths.
The recalled product includes Nara Organics Whole Milk Infant Formula in 700-gram cans with UPC 860013251901 and 400-gram cans with UPC 860013251918, according to the FDA recall notice. The agency and the company said all lots currently on the market are covered. The FDA notice lists these lot codes: 408125075E14F2, 708125076E14F2, 708125083E14F2, 408125139E14F2, 708125141E14F2, 708125145E14F2, 708125174E14F2, 709125273E14F2, 709125280E14F2, 709125288E14F2, 409125307E14F2, 70926019ENNB, 70926029ENNB, 70926035ENNB, 70926039ENNB, and 70926042ENNB.
Federal officials have not published an FDA recall number or hazard classification in the materials available on the agency’s recall page and outbreak advisory. The FDA said the illnesses began between April and May 2026, with the last illness onset reported as May 31, 2026. Nara said the formula had not tested positive for Clostridium botulinum as of its recall notice, but the company said it moved ahead with the recall because of the seriousness of the cases.
What is confirmed in California, Pennsylvania, and Washington
The FDA said one illness was identified in California, one in Pennsylvania, and one in Washington. All three infants were between 2 and 5 months old, according to reporting that cited federal officials, and all were hospitalized and treated. No deaths have been reported.
What is not yet known is where, within those three states, the affected families purchased or used the product. Federal officials have said the formula was distributed nationally through Target stores, Target.com, and Nara.com between July 2025 and June 2026, but they have not released a state-by-state distribution list or identified specific cities or store locations tied to the illnesses.
The company’s consumer guidance varies by seller. Nara said customers who ordered from Nara.com in May or June 2026 will be refunded automatically, while customers with cans purchased through Nara.com can submit photos of the can bottoms to request refunds. For 700-gram cans bought at Target, Nara said customers should return them through a local Target store or follow Target’s online return process. Nara also said Target did not sell the 400-gram cans.
Investigators are still testing product as the inquiry widens
The FDA said its investigation is ongoing and that leftover formula from affected households and unopened samples from the implicated lots are still being tested. As of the agency’s June 26 update, officials in two states had collected leftover formula, and the FDA said results were expected in the coming weeks.
The agency also added new supply-chain context on June 26. FDA investigators said the Nara lots linked to the illnesses were made with milk supplied by Organic West Milk and spray dried by Dairy Farmers of America. The FDA said those are the same suppliers involved in the separate ByHeart powdered infant formula botulism outbreak disclosed in late 2025, but the agency also said there is not yet enough evidence to determine whether that shared sourcing is the route of contamination in the Nara investigation.
For families, the immediate guidance remains specific. The FDA said parents and caregivers should stop using Nara Organics Whole Milk Organic Infant Formula immediately, record the lot number and use-by date, and consider keeping opened cans labeled “DO NOT USE” for at least a month in case health officials need to test them. The agency also said the recall does not raise broader infant formula shortage concerns because Nara Organics represents less than 1% of U.S. infant formula sales.